Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,841 | 8,935 | 5,625 | 4,607 | 4,018 |
| Marketable Securities | 7,793 | 7,973 | 6,967 | 6,727 | 7,967 |
| Receivables | 3,315 | 2,216 | 5,260 | 5,096 | 3,955 |
| Income taxes - deferred | 99 | 98 | 95 | 84 | 80 |
| TOTAL | $20,340 | $19,549 | $18,274 | $16,958 | $16,430 |
| Non-Current Assets | |||||
| Intangibles | 300 | 323 | 216 | 232 | 248 |
| Other Non-Current Assets | 4,687 | 4,755 | 4,763 | 4,163 | 4,243 |
| TOTAL | $4,987 | $5,078 | $4,979 | $4,395 | $4,491 |
| Total Assets | $25,326 | $24,627 | $23,252 | $21,353 | $20,921 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 719 | 877 | 634 | 539 | 661 |
| TOTAL | $867 | $1,024 | $782 | $746 | $1,200 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 69 | 69 | 69 | 69 | 78 |
| TOTAL | $104 | $121 | $138 | $156 | $173 |
| Total Liabilities | $970 | $1,145 | $920 | $902 | $1,373 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,477 | 6,395 | 6,388 | 6,338 | 6,340 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | 6,307 | 5,729 | 4,975 | 3,249 | 2,070 |
| Other shareholders' equity | -352 | 318 | 399 | 466 | -323 |
| TOTAL | $24,356 | $23,482 | $22,332 | $20,451 | $19,548 |
| Total Liabilities And Equity | $25,326 | $24,627 | $23,252 | $21,353 | $20,921 |